432 related articles for article (PubMed ID: 8873551)
1. Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint.
Nagasaka H; Awad H; Yaksh TL
Anesthesiology; 1996 Oct; 85(4):808-16. PubMed ID: 8873551
[TBL] [Abstract][Full Text] [Related]
2. Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats.
Sluka KA; Deacon M; Stibal A; Strissel S; Terpstra A
J Pharmacol Exp Ther; 1999 May; 289(2):840-6. PubMed ID: 10215661
[TBL] [Abstract][Full Text] [Related]
3. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
4. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
5. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
Parsons CG; West DC; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.
Kondo I; Marvizon JC; Song B; Salgado F; Codeluppi S; Hua XY; Yaksh TL
J Neurosci; 2005 Apr; 25(14):3651-60. PubMed ID: 15814796
[TBL] [Abstract][Full Text] [Related]
7. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Bhargava HN; Cao YJ; Zhao GM
Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462
[TBL] [Abstract][Full Text] [Related]
8. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
9. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
10. Actions of opioids on respiratory activity via activation of brainstem mu-, delta- and kappa-receptors; an in vitro study.
Takita K; Herlenius EA; Lindahl SG; Yamamoto Y
Brain Res; 1997 Dec; 778(1):233-41. PubMed ID: 9462896
[TBL] [Abstract][Full Text] [Related]
11. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
12. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
Randich A; Robertson JD; Willingham T
Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
[TBL] [Abstract][Full Text] [Related]
13. Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats.
Kakinohana M; Nakamura S; Fuchigami T; Davison KJ; Marsala M; Sugahara K
Br J Anaesth; 2006 Jan; 96(1):88-94. PubMed ID: 16317029
[TBL] [Abstract][Full Text] [Related]
14. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
[TBL] [Abstract][Full Text] [Related]
18. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Cao YJ; Bhargava HN
Brain Res; 1997 Mar; 752(1-2):250-4. PubMed ID: 9106464
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of intrathecally injected mu, delta and kappa opioid receptor agonists in rabbits.
Oğütman C; Kaputlu I; Sadan G
J Auton Pharmacol; 1995 Dec; 15(6):443-50. PubMed ID: 8920161
[TBL] [Abstract][Full Text] [Related]
20. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
